Betty A. Mincey

Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors

Betty A. Mincey, Mei Sheng Duh, Simu K. Thomas et al. · Clinical Breast Cancer · 2006 · 92 citations

Medicine, Oncology, Pharmacology +12

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

Stephanie L. Hines, Betty A. Mincey, Jeff A. Sloan et al. · Journal of Clinical Oncology · 2008 · 86 citations · Full text

Medicine, Oncology, Bone Metabolism +13

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

Stephanie L. Hines, Betty A. Mincey, Todor Dentchev et al. · Breast Cancer Research and Treatment · 2009 · 85 citations

Pharmacy, Oncology, Pharmacotherapy +17

Pilot Evaluation of Citalopram for the Treatment of Hot Flashes in Women with Inadequate Benefit from Venlafaxine

Charles L. Loprinzi, Patrick J. Flynn, Lisa A. Carpenter et al. · Journal of Palliative Medicine · 2005 · 47 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Antibiotic prescribing practices in a teaching clinic: comparison of resident and staff physicians.

Betty A. Mincey, Mark A. Parkulo · PubMed · 2001 · 44 citations

Pharmacy, Medical Education, Antimicrobial Pharmacotherapy +12